---
input_text: 'Correlates of transfusion transmissible infections among patients with
  sickle cell disease in Nigeria: case-control study. Transfusion transmissible infections
  (TTIs) such as Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency
  Virus (HIV) are among the most frequent complications in individuals with Sickle
  Cell Disease (SCD). We investigated factors associated with TTIs in SCD patients
  and controls in South-west Nigeria. A total of 2,034 participants with or without
  SCD were recruited in a matched case-control study. HIV, HBV and HCV infections
  were diagnosed using commercialy available ELISA kits (Biorad, Paris). Samples positive
  for HIV ELISA were further confirmed using Western blot. Data were analyzed using
  descriptive statistics, paired/independent t-test and logistic regression at p =
  .05. Proportion with HBV was higher among those with multiple sexual partners (12.7%),
  tattoo/body incision (11.8%), and sharing of sharp objects (7.3%), but HIV was only
  higher among participants with history of tattoo/body incision (1.5%). Prevalence
  of TTIs was similar among participants with or without transfusion. History of sharing
  sharp objects (adjusted odds ratios (aOR) = 1.72; 95%CI:1.11-2.66) and tattoo/body
  incision (aOR = 1.89; 95%CI:1.22-2.94) almost doubled the risk of HBV. TTIs are
  endemic in the studied area. Certain lifestyles predispose people to TTIs than having
  blood transfusion. Population-based intervention targeting lifestyle changes may
  reduce the risk of TTIs in the study area.Abbrveviations AA: Hemoglobin AA; AC:
  Hemoglobin AC; aOR: adjusted Odds Ratios; AS: Hemoglobin AS; CHOP: Children Outpatient;
  CI: Confidence Interval; EDTA: Ethylenediamine Tetraacetic Acid; GOP: General Outpatient;
  HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; HIV: Human Immunodeficiency Virus;
  HPLC: High Performance Liquid Chromatography; IAMRAT: Advanced Medical Research
  & Training; IDU: Injection Drug Use; MOP: Medical Outpatient; SC: Hemoglobin SC;
  SCD: Sickle cell disease; SD: Standard Deviation; SF: Hemoglobin SF; SS: Hemoglobin
  SS; STDs: Sexually Transmitted Diseases; TTI: Transfusion transmissible infections;
  UCH: University College Hospital Ibadan; UI: University of Ibadan.'
raw_completion_output: |-
  primary_disease: Sickle cell disease

  medical_actions: Use of ELISA kits for diagnosis; Western blot confirmation

  symptoms: Hepatitis B Virus (HBV); Hepatitis C Virus (HCV); Human Immunodeficiency Virus (HIV)

  chemicals: 

  action_annotation_relationships: Use of ELISA kits for diagnosis TREATS Hepatitis B Virus (HBV) IN Sickle cell disease; Use of ELISA kits for diagnosis TREATS Hepatitis C Virus (HCV) IN Sickle cell disease; Use of ELISA kits for diagnosis TREATS Human Immunodeficiency Virus (HIV) IN Sickle cell disease; Western blot confirmation TREATS Human Immunodeficiency Virus (HIV) IN Sickle cell disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Western blot confirmation TREATS Human Immunodeficiency Virus (HIV) IN Sickle cell disease

  ===

extracted_object:
  primary_disease: MONDO:0011382
  medical_actions:
    - Use of ELISA kits for diagnosis
    - Western blot confirmation
  symptoms:
    - Hepatitis B Virus (HBV)
    - Hepatitis C Virus (HCV)
    - Human Immunodeficiency Virus (HIV)
  action_annotation_relationships:
    - subject: Use of ELISA kits for diagnosis
      predicate: TREATS
      object: Hepatitis B Virus (HBV)
      qualifier: MONDO:0011382
      subject_extension: ELISA kits
    - subject: diagnosis
      predicate: TREATS
      object: Hepatitis C Virus (HCV)
      qualifier: MONDO:0011382
      subject_qualifier: use of
      subject_extension: ELISA kits
    - subject: <diagnosis>
      predicate: <TREATS>
      object: <Human Immunodeficiency Virus (HIV)>
      qualifier: <Sickle cell disease>
      subject_qualifier: <Use of>
      object_qualifier: <>
      subject_extension: <ELISA kits>
      object_extension: <>
    - subject: <Western blot confirmation>
      predicate: <TREATS>
      object: <Human Immunodeficiency Virus (HIV)>
      qualifier: <Sickle cell disease>
      subject_qualifier: <Not applicable>
      object_qualifier: <Not applicable>
      subject_extension: <Not provided as the text does not specify a chemical or
        drug>
      object_extension: <Not provided as the text does not specify a specific aspect
        of the object>
named_entities:
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0000747
    label: Allogeneic hematopoietic stem cell transplantation (HSCT)
  - id: HP:0007760
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0020380
    label: Sickle cell anemia (SCA)
  - id: HP:0001297
    label: Stroke
  - id: CHEBI:44423
    label: Hydroxyurea
  - id: MONDO:0011382
    label: sickle cell anemia
  - id: MAXO:0000149
    label: allogeneic human leukocyte antigen (HLA)-matched sibling and haploidentical
      hematopoietic cell transplant (HCT)
  - id: CHEBI:17303
    label: morphine
  - id: CHEBI:35482
    label: opioid analgesics
  - id: HP:0012532
    label: chronic pain
  - id: CHEBI:6121
    label: ketamine
  - id: HP:0012531
    label: pain
  - id: MAXO:0000748
    label: fecal microbiota transplantation (FMB)
  - id: CHEBI:26666
    label: SCFA
  - id: CHEBI:17968
    label: butyrate
  - id: CHEBI:31011
    label: valerate
  - id: CHEBI:17272
    label: propionate
  - id: MONDO:0005399
    label: Venous thromboembolism (VTE)
  - id: HP:0002140
    label: Ischemic cerebrovascular accidents
  - id: HP:0002098
    label: respiratory distress
  - id: CHEBI:8735
    label: PAINReportIt(R)
  - id: MAXO:0000066
    label: Oxygen supplementation
  - id: MAXO:0000756
    label: Blood transfusions
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: antibiotic
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001395
    label: Liver fibrosis
  - id: MAXO:0000750
    label: conditioning regimen (alemtuzumab, total body irradiation, and sirolimus
      for GVHD prophylaxis)
  - id: CHEBI:9168
    label: sirolimus
  - id: MONDO:0005812
    label: Influenza
  - id: MONDO:0100096
    label: COVID-19
  - id: MONDO:0003847
    label: Genetic diseases
  - id: MONDO:0002492
    label: Acute Kidney Injury (AKI)
  - id: CHEBI:35457
    label: angiotensin-converting enzyme inhibitors
  - id: HP:0001919
    label: AKI
  - id: MONDO:0005300
    label: chronic kidney disease
  - id: HP:0031589
    label: Suicidal ideation
  - id: HP:0000739
    label: anxiety
  - id: MONDO:0005252
    label: heart failure
  - id: MONDO:0005249
    label: pneumonia
  - id: MONDO:0005068
    label: MI
  - id: MONDO:0011751
    label: COPD
  - id: HP:0001907
    label: Thromboembolic events
  - id: HP:0100602
    label: Preeclampsia
  - id: HP:0001511
    label: Fetal growth restriction
  - id: HP:0001622
    label: Preterm birth
  - id: HP:0003826
    label: Stillbirth
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: CHEBI:18050
    label: l-glutamine
  - id: HP:0008209
    label: Premature ovarian insufficiency
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: CHEBI:17115
    label: Statistical Software Package(s)
  - id: HP:0001903
    label: anemia
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MONDO:0010094
    label: sickle cell trait (SCT)
  - id: HP:0000822
    label: hypertension
  - id: HP:0001626
    label: cardiovascular disease
  - id: HP:0000093
    label: proteinuria
  - id: HP:0000083
    label: kidney failure
  - id: HP:0000112
    label: kidney disease
  - id: HP:0001997
    label: Gout
  - id: HP:0002863
    label: myelodysplastic syndrome
  - id: HP:0003418
    label: Back pain
  - id: HP:0002018
    label: Nausea
  - id: HP:0002019
    label: Constipation
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:50443
    label: hematopoietic stem cells (HSCs)
  - id: HP:0000789
    label: infertility
  - id: CHEBI:41879
    label: dexamethasone
  - id: CHEBI:64360
    label: Tocilizumab
  - id: MONDO:0011549
    label: Hyperhemolysis syndrome (HHS)
  - id: HP:0001896
    label: Reticulocytopenia
  - id: MAXO:0001017
    label: Vaccination
  - id: CHEBI:66919
    label: Ruxolitinib
  - id: CHEBI:76612
    label: Ibrutinib
  - id: MONDO:0013517
    label: beta-thalassemia (beta-TM)
  - id: MONDO:0005047
    label: Infertility
  - id: CHEBI:46195
    label: Acetaminophen
  - id: CHEBI:41423
    label: Celecoxib
  - id: CHEBI:63629
    label: Tizanidine
  - id: CHEBI:6129
    label: Ketorolac
  - id: MONDO:0005290
    label: Rhabdomyolysis
  - id: MAXO:0001121
    label: Kidney biopsy
  - id: MAXO:0000387
    label: Muscle biopsy
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: MONDO:0005632
    label: Acute chest syndrome
  - id: CHEBI:16480
    label: nitric oxide
  - id: CHEBI:28304
    label: heparin
  - id: MONDO:0013730
    label: Graft versus host disease (GvHD)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0002615
    label: Hypotension
  - id: HP:0001662
    label: Bradycardia
  - id: CHEBI:119915
    label: Fentanyl
  - id: MONDO:0006497
    label: Chronic Pancreatitis (CP)
  - id: MAXO:0035049
    label: Endoscopic retrograde cholangiopancreatography
  - id: MAXO:0000004
    label: Surgical procedures
  - id: MAXO:0000088
    label: Dietary interventions
  - id: MONDO:0005003
    label: Chronic Pancreatitis
  - id: CHEBI:17334
    label: penicillin
  - id: HP:0000716
    label: Depression
  - id: MONDO:0001754
    label: Eclampsia
  - id: MONDO:0010088
    label: Musculoskeletal diseases (MSD)
  - id: HP:0034057
    label: congenital defects
  - id: MAXO:0001077
    label: Splenectomy
  - id: HP:0010972
    label: Ineffective erythropoiesis
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: HP:0000026
    label: Testicular failure
  - id: CHEBI:143719
    label: Hib
  - id: CHEBI:143712
    label: menC
